Treatment for Wheezing and Coughing in a 45-Year-Old Female
Start with a short-acting beta-agonist (salbutamol 200-400 µg or terbutaline 500-1000 µg via hand-held inhaler four times daily) and immediately assess severity to determine if this represents asthma or requires escalation. 1
Initial Assessment and Severity Stratification
First, determine the severity of presentation:
Mild Presentation
- Patient can speak in complete sentences
- No significant respiratory distress
- Treatment: Hand-held inhaler with salbutamol 200-400 µg or terbutaline 500-1000 µg four hourly 1
Moderately Severe Presentation
- Some difficulty speaking
- Increased work of breathing
- Treatment: Salbutamol 400 µg or terbutaline 1000 µg four hourly via hand-held inhaler, or consider nebulizer 1
Severe Presentation
- Cannot complete sentences
- Respiratory rate >25/min
- Heart rate >110/min
- Peak flow <50% best
- Treatment: Oxygen plus oral steroids plus nebulized salbutamol 5 mg or terbutaline 10 mg, repeated 4-6 hourly. If no improvement, add ipratropium bromide 500 µg and consider hospital admission 1
Diagnostic Approach for Chronic Symptoms (>8 weeks)
If symptoms persist beyond acute treatment, consider these top five diagnoses systematically:
1. Cough Variant Asthma
- Key features: Cough may be the only manifestation, often worse at night, after exercise, or with allergen exposure 2
- Diagnosis: Spirometry showing airway hyperresponsiveness with methacholine challenge 3
- Treatment: Follow national asthma guidelines with inhaled corticosteroids as first-line therapy 3
2. Eosinophilic Bronchitis
- Key features: Chronic cough with eosinophilic airway inflammation but NO airway hyperresponsiveness 3
- Treatment: Responds to inhaled corticosteroids 3
3. Gastroesophageal Reflux Disease (GORD)
- Key features: May lack typical reflux symptoms; accounts for 5-41% of chronic cough cases 3
- Treatment:
4. Upper Airway Cough Syndrome (Post-Nasal Drip)
- Key features: Nasal stuffiness, sinusitis, sensation of secretions draining posteriorly 3
- Treatment:
5. COPD (less likely at age 45 unless significant smoking history)
- Consider if patient has smoking history
- Requires spirometry for diagnosis
Critical Pitfalls to Avoid
- Do NOT assume asthma without objective testing: Spirometry is essential; patient perception of airflow obstruction is highly variable 2
- Do NOT use peak flow meters for diagnosis: They are designed for monitoring, not diagnosis, due to wide variability 2
- Do NOT stop PPI therapy prematurely: Requires minimum 8 weeks for adequate trial 3
- Do NOT overlook medication-induced cough: Check for ACE inhibitors, which are a common reversible cause 4
Mandatory Initial Workup
Before extensive testing:
- Chest radiography 3, 4
- Spirometry 3, 2, 4
- Exhaled nitric oxide (if available) 4
- Blood eosinophil count 4
Treatment Algorithm
- Immediate: Start bronchodilator based on severity (see above)
- Week 1-2: Assess response and eliminate high-risk factors (smoking, ACE inhibitors)
- Week 2-6: Empiric treatment for most likely diagnosis based on clinical features
- Week 6-8: If no response, proceed to additional diagnostic testing
- Beyond 8 weeks: Consider refractory cough management with low-dose morphine (preferred), gabapentin, or pregabalin 4
Special Considerations for This Age Group
At 45 years old, be particularly vigilant for:
- New-onset asthma (uncommon but possible) 5
- Occupational exposures
- Medication-induced cough
- Early COPD if smoking history present
The key is rapid assessment of severity, immediate bronchodilator therapy, and systematic evaluation of the five most common causes before pursuing extensive diagnostic testing.